Felip, E., & Rosell, R. (2008). Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC). Dove Medical Press.
Citação norma ChicagoFelip, Enriqueta, and Rafael Rosell. Pemetrexed As Second-line Therapy for Advanced Non-small-cell Lung Cancer (NSCLC). Dove Medical Press, 2008.
MLA citiranjeFelip, Enriqueta, and Rafael Rosell. Pemetrexed As Second-line Therapy for Advanced Non-small-cell Lung Cancer (NSCLC). Dove Medical Press, 2008.
Opozorilo: Ti citati niso vedno 100% točni.